Q3 2025 Management View CEO Marc Parent highlighted a record $20.3 billion adjusted backlog, supported by $2.2 billion in new orders during the quarter. Civil segment backlog grew to $8.8 billion, a ...

Elite Pharmaceuticals, with a market capitalization of $531 million, reported a decline in third-quarter revenue for 2024, falling 8% from the previous year. Despite a strong nine-month performance, ...